Frazier Life Sciences Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Frazier Life Sciences Management’s Portfolio THRX Stock Details THRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$8.58M	Sell
2023 Q3	$6.05M	Hold
2023 Q2	$21M	Hold
2023 Q1	$20M	Buy
2022 Q4	$6.96M	Buy